Management of patients with atrial fibrillation has long centered on the relative merits of rate control versus rhythm control. The CASTLE-AF trial evaluated catheter ablation as a treatment for patients with both heart failure with reduced ejection fraction and atrial fibrillation. Listen to this week’s podcast episode to learn about the results of this new trial and how the catheter ablation impacted clinical outcomes. 
Guest: Alan Ehrlich MD